127 related articles for article (PubMed ID: 15171614)
1. Exploitation of cell cycle and cell death controls by adenoviruses: the road to a productive infection.
Russell IA; Royds JA; Braithwaite AW
Prog Mol Subcell Biol; 2004; 36():207-43. PubMed ID: 15171614
[No Abstract] [Full Text] [Related]
2. Smarter viruses. Onyx pharmaceuticals, Inc.
Wells WA
Chem Biol; 2000 Dec; 7(12):R223-4. PubMed ID: 11137823
[No Abstract] [Full Text] [Related]
3. DNA replication of first-generation adenovirus vectors in tumor cells.
Steinwaerder DS; Carlson CA; Lieber A
Hum Gene Ther; 2000 Sep; 11(13):1933-48. PubMed ID: 10986565
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus 5 E1A-Mediated Suppression of p53 via FUBP1.
Frost JR; Mendez M; Soriano AM; Crisostomo L; Olanubi O; Radko S; Pelka P
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743362
[TBL] [Abstract][Full Text] [Related]
5. Nuclear organization of replication and gene expression in adenovirus-infected cells.
Bridge E; Pettersson U
Curr Top Microbiol Immunol; 1995; 199 ( Pt 1)():99-117. PubMed ID: 7555063
[No Abstract] [Full Text] [Related]
6. Formation of adenovirus DNA replication compartments.
Hidalgo P; Gonzalez RA
FEBS Lett; 2019 Dec; 593(24):3518-3530. PubMed ID: 31710378
[TBL] [Abstract][Full Text] [Related]
7. The Persistent Mystery of Adenovirus Persistence.
King CR; Zhang A; Mymryk JS
Trends Microbiol; 2016 May; 24(5):323-324. PubMed ID: 26916790
[No Abstract] [Full Text] [Related]
8. Imaging the adenovirus infection cycle.
Pied N; Wodrich H
FEBS Lett; 2019 Dec; 593(24):3419-3448. PubMed ID: 31758703
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus and cell cycle control.
Ben-Israel H; Kleinberger T
Front Biosci; 2002 May; 7():d1369-95. PubMed ID: 11991831
[TBL] [Abstract][Full Text] [Related]
10. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
11. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus Core Proteins: Structure and Function.
Kulanayake S; Tikoo SK
Viruses; 2021 Feb; 13(3):. PubMed ID: 33671079
[TBL] [Abstract][Full Text] [Related]
13. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells.
Wilcock D; Lane DP
Nature; 1991 Jan; 349(6308):429-31. PubMed ID: 1671528
[TBL] [Abstract][Full Text] [Related]
14. (Re-)Engineering tumor cell-selective replicating adenoviruses: a step in the right direction toward systemic therapy for metastatic disease.
Dubensky TW
Cancer Cell; 2002 May; 1(4):307-9. PubMed ID: 12086842
[TBL] [Abstract][Full Text] [Related]
15. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.
Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R
J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534
[TBL] [Abstract][Full Text] [Related]
16. Role of adenovirus structural components in the regulation of adenovirus infection.
Russell WC; Kemp GD
Curr Top Microbiol Immunol; 1995; 199 ( Pt 1)():81-98. PubMed ID: 7555062
[No Abstract] [Full Text] [Related]
17. The adenovirus major core protein VII is dispensable for virion assembly but is essential for lytic infection.
Ostapchuk P; Suomalainen M; Zheng Y; Boucke K; Greber UF; Hearing P
PLoS Pathog; 2017 Jun; 13(6):e1006455. PubMed ID: 28628648
[TBL] [Abstract][Full Text] [Related]
18. Subversion of the actin cytoskeleton during viral infection.
Taylor MP; Koyuncu OO; Enquist LW
Nat Rev Microbiol; 2011 Jun; 9(6):427-39. PubMed ID: 21522191
[TBL] [Abstract][Full Text] [Related]
19. Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
van Beusechem VW; van den Doel PB; Grill J; Pinedo HM; Gerritsen WR
Cancer Res; 2002 Nov; 62(21):6165-71. PubMed ID: 12414643
[TBL] [Abstract][Full Text] [Related]
20. Cancer therapy based on p53.
McCormick F
Cancer J Sci Am; 1999; 5(3):139-44. PubMed ID: 10367167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
